New study to see if RSV shot for pregnant women shields newborns from severe illness
NCT ID NCT07122661
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 25 times
Summary
This study looks at how well the RSVpreF vaccine (ABRYSVO) works when given during pregnancy to protect babies from severe RSV disease. Researchers will review health records of infants up to 12 months old who were hospitalized with breathing problems in Australia. No new treatments or visits are involved—only existing data from hospitals and immunization registries.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY TRACT DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
Sydney, Australia
Conditions
Explore the condition pages connected to this study.